A randomised, double-blind, placebo controlled trial of the effect versus placebo of twice daily doses of mannitol (80mg) for one week on nasal mucociliary clearance in healthy adults and adults with allergic rhinitis or chronic sinusitis.
Phase of Trial: Phase III
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Mannitol (Primary) ; Mannitol (Primary)
- Indications Allergic rhinitis; Chronic sinusitis
- Focus Therapeutic Use
- Acronyms MCC123
- 08 Jun 2016 Status changed from recruiting to completed.
- 15 May 2009 New trial record